Skip to main content
Log in

The future of clinical pharmacology — Rebuttal of an editor's headache

  • Letter To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Ejvinsson G (1978) Effect of quinidine on plasma concentration of digoxin. Br Med J [I]: 279–280

    Google Scholar 

  • Habermann E (1981) Can the future of pharmacology be anticipated? TIPS 2: 56–59

    Google Scholar 

  • Odar-Cederlöf I, Lunde PKM, Sjöqvist F (1970) Abnormal pharmacokinetics of diphenylhydantoin in a patient with uremia. Lancet 2 (Letter): 831–832

    Google Scholar 

  • Sjöqvist F (1980) Clinical Pharmacology. Proceedings of the First World Conference on Clinical Pharmacology and Therapeutics. London Aug 1980. Turner P (ed), Mac Millan Publications London, pp XII-XVI

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sjöqvist, F., Gross, F. The future of clinical pharmacology — Rebuttal of an editor's headache. Eur J Clin Pharmacol 23, 471–473 (1982). https://doi.org/10.1007/BF00637490

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00637490

Key words

Navigation